MPS5304 Regulatory science and monitoring medicine use
Faculty of Pharmacy and Pharmaceutical Sciences
MPS5304 Regulatory science and monitoring medicine use is a level 5, 6-credit-point, postgraduate unit from the Faculty of Pharmacy and Pharmaceutical Sciences, offered in 2024 in Semester 1 at Parkville. It has no prerequisites.
- Credit points
- 6
- Offered in 2024
- Semester 1
- Parkville
- Assessment
- No exam
- 5 tasks
This is the 2024 handbook entry. See the 2027 entry.
Reviews
No reviews yetNo reviews yet. Be the first to review MPS5304.
Requisites
Before MPS5304
No prerequisites or corequisites besides the enrolment rules below.
After MPS5304
No unit lists MPS5304 as a prerequisite in the 2024 handbook.
Enrolment rules
Prerequisite: one of MPS5201, MPS5202, MPS5203 or MPS5204
Overview
This unit guides you through the paradigm in which approved medicines are monitored and regulated in their wider clinical use. In the unit, you will build a foundation understanding of pharmacoepidemiology, pharmacoeconomics, and the safe use of medicines through the lens of evidence-based practice. You will explore the frameworks used to evaluate medicine use and cost-effectiveness to inform policy and funding decisions, as well as drive clinical and consumer decision making. Upon completing this unit, you will have a comprehensive view of the issues surrounding the effective use of medicines in the broader population, and how to address these global issues from a practical perspective.
Offerings in 2024
| Teaching period | Campus | Mode |
|---|---|---|
| First semester | Parkville | On campus |
Assessment
- Workshop assessment20%
- Critical appraisal of a piece of research evidence20%
- Evidence Synthesis20%
- Evaluation of cost-effectiveness20%
- Oral PresentationCompetency hurdle20%
Learning outcomes
When you finish this unit, you should be able to:
- 1
Retrieve and appraise the application of research evidence as the basis for clinical and regulatory decision making
- 2
Critically examine and report on the pharmacoepidemiology of medicines and the assessment of their post-marketing safety in a contemporary context
- 3
Explain the principles of health economics and pharmacoeconomics
- 4
Explain the development and application of clinical practice guidelines, and systematic reviews and meta-analyses as sources of evidence about the benefits and risks of medicine treatment
- 5
Evaluate evidence-based practice approach, with consideration of costs and outcomes
- 6
Synthesise comprehensive evidence considering the complex interplay of comparative effectiveness, and economics, legal, ethical, social and sustainability aspects
- 7
Use effective written and oral communication skills to communicate findings related broadly to regulatory science and the monitoring of medicine use in the wider population.
Workload and teaching
- Workshops24 hours
- Applied sessions12 hours
- Teaching approachRole play
- Teaching approachIndustry-based learning
- Teaching approachEnquiry-based learning
- Teaching approachActive learning
- Teaching approachPeer assisted learning
- 24 hours of preparation for classes
- Twelve 1-hour applied classes
- Twelve 2-hour workshops
- 36 hours of independent work
- 48 hours of group work
Learning resources
Technology resources
This unit requires access to a laptop that meets minimum specifications. Free specialist software is available via MoVE.
Contacts
- Unit Coordinators
- Dr Lauren May
- Chief Examiners
- Dr Lauren May
Common questions
What are the prerequisites for MPS5304?
MPS5304 has no prerequisites, but enrolment rules apply.
When is MPS5304 offered?
In 2024, MPS5304 runs in Semester 1 at Parkville.
Does MPS5304 have an exam?
No. MPS5304 has 5 assessment tasks and no exam.